Bio Rad Laboratories Inc
NYSE:BIO
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
263.97
374.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Bio Rad Laboratories Inc
Bio Rad Laboratories Inc
Accrued Liabilities
Bio Rad Laboratories Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bio Rad Laboratories Inc
NYSE:BIO
|
Accrued Liabilities
$188.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
41%
|
CAGR 10-Years
0%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accrued Liabilities
$5.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Danaher Corp
NYSE:DHR
|
Accrued Liabilities
$2.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accrued Liabilities
$364.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accrued Liabilities
$573m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bio Rad Laboratories Inc
Glance View
Bio-Rad Laboratories Inc. is a global leader in the life sciences and clinical diagnostics industries, renowned for its innovative technologies that empower researchers and healthcare professionals. Founded in 1952, Bio-Rad has developed a diverse portfolio of products that serve a wide range of applications, from advancing scientific research in genomics and proteomics to enhancing diagnostic capabilities in clinical laboratories. The company operates through two key segments: Life Science and Diagnostics, which together create synergies that drive growth. With a commitment to quality and customer satisfaction, Bio-Rad has built a reputation for reliability and technical excellence, making it a trusted partner in the quest for scientific breakthroughs and improved patient care. Investors looking at Bio-Rad will find a resilient company with strong fundamentals and a consistent track record of performance. The firm benefits from ongoing trends in healthcare and biotechnology, with increasing demand for precision medicine and advanced molecular diagnostics leading to robust revenue streams. Bio-Rad's global footprint and extensive distribution network not only mitigate risks associated with market fluctuations but also position the company to capitalize on emerging technologies and expanding international markets. With a strategic focus on innovation and a history of prudent financial management, Bio-Rad Laboratories offers investors an opportunity to be part of a company that is at the forefront of scientific advancement while also delivering solid returns.
See Also
What is Bio Rad Laboratories Inc's Accrued Liabilities?
Accrued Liabilities
188.9m
USD
Based on the financial report for Sep 30, 2024, Bio Rad Laboratories Inc's Accrued Liabilities amounts to 188.9m USD.
What is Bio Rad Laboratories Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
0%
Over the last year, the Accrued Liabilities growth was -3%. The average annual Accrued Liabilities growth rates for Bio Rad Laboratories Inc have been -12% over the past three years , 41% over the past five years .
You don't have any saved screeners yet
